Reuters logo
BRIEF-BioDelivery Sciences Says ‍Ohio Workers Compensation Approved Change To Formulary
November 27, 2017 / 12:14 PM / 21 days ago

BRIEF-BioDelivery Sciences Says ‍Ohio Workers Compensation Approved Change To Formulary

Nov 27 (Reuters) - BioDelivery Sciences International Inc :

* BIODELIVERY SCIENCES - ‍OHIO BUREAU OF WORKERS COMPENSATION APPROVED CHANGE TO ITS FORMULARY RESULTING IN FAVORABLE POSITIONING FOR BELBUCA, BUNAVAIL

* BIODELIVERY SCIENCES INTERNATIONAL INC - ‍BELBUCA WILL BE ADDED TO FORMULARY AS A TIER 1 LONG-ACTING OPIOID WITHOUT RESTRICTIONS​

* BIODELIVERY SCIENCES INTERNATIONAL INC - ‍CHANGES TO FORMULARY WILL GO INTO EFFECT APRIL 1, 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below